| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |